Market Overview

Rumor: Big Stake In Allergan Acquired By Valeant Supporter Paulson

Share:
Related VRX
Mid-Afternoon Market Update: CIFC Rises Following Acquisition News; Marathon Oil Shares Slide
10 Biggest Mid-Day Gainers For Monday
Valeant: $55 Price Target Reaffirmed (Seeking Alpha)
Related AGN
Pfizer Has Had A Busy M&A Year...Or Has It?
The Market In 5 Minutes: Up And Down Week Comes To A Close
Tracking Wallace Weitz's Weitz Investment Management Portfolio - Q2 2016 Update (Seeking Alpha)

Allergan Inc. (NYSE: AGN) shares bumped up more than 2 percent on a rumor that Hedge fund Paulson & Co. acquiredsix6 million shares.

The report by Reuters said Paulson backs Valeant Pharmaceuticals (NYSE: VRX) in its proxy battle to acquire Allergan and the new stake puts Paulson among Allergan's top holders.

Valeant needs support from 25 percent of Allergan's holders in order to call a special shareholder meeting to vote on its $53 billion bid.

Allergan has called the offer "grossly inadequate."

With a current market capitalization of about $50.3 billion, Allergan traded recently at $69.02, up 2.2 percent.

Posted-In: News Rumors

 

Related Articles (AGN + VRX)

View Comments and Join the Discussion!